CRO for Clinical Trials in China

China is one of the leading countries in the global clinical trial space. By June 2021, the clinical trial database of the United States (clinicaltrials.gov) showed a total of 21,062 clinical studies including the participation of Chinese sites.

With an extensive population of around 1.4 billion, China counts on a vast number of clinical sites to run clinical trials with very high recruitment rates. The main Chinese cities in which clinical trials are conducted are Shanghai and Beijing. 

Sofpromed offers high-quality CRO services for biotechnology and pharmaceutical companies interested in conducting clinical studies in China.

Our CRO services in China include:

  • Regulatory
  • Ethics committee submissions
  • Clinical operations
  • Hospital selection and activation
  • Monitoring visits
  • Data management
  • Statistical programming
  • Biostatistics
  • Medical writing
  • Clinical supply management
  • Drug logistics

In China, we provide CRO services for clinical trial sponsors in the following therapeutic areas:

  • Oncology 
  • Hematology
  • Cardiovascular
  • Metabolic
  • Central nervous system (CNS)
  • Dermatology
  • Infectious diseases
  • Respiratory diseases
  • Pain